Oct 29 2003 KO22599 7 of Z
Attachment I
510(K) Summary
Medical Laser Technologies, LLC MLT Erbium: YAG Laser System

This 510(K) Summary of safety and effectiveness for the MLT Erbium: YAG Laser System is

submitted in accordance with the requirements of SMDA 1990 and following guidance concerning

the organization and content of a 510(K) summary. :

Applicant: Medical Laser Technologies, LLC

Address: 516 Scott Street
Homewood, AL 35209

Contact Person: Mark Rohrer, Managing Member

Telephone: 205-290-8251

Telefax: 205-290-4269

Preparation Date: July 1, 2003

Device Trade Name: Medical Laser Technologies, LLC, MLT Erbium: YAG Laser

System

Common Name: Erbium:Y AG laser devise

Classification Name: Instrument, Powered, Laser
79-GEX
21 CFR 878-48

Legally Marketed Predicate Schwartz Electro-Optics TriLase 2940, K#954013

Device . Cell Robotics Er: Y AG Laser System, K#970461

: Asceplion-Meditec Dermastar Er: YAG Laser System, K#014057

Description of the Device The Medical Laser Technologies, LLC MLT Erbium: YAG Laser

System is an Er:YAG laser producing emission at a
wavelength of 2940 nm. The laser consist of two
interconnected sections: The cabinet which houses the
power supply, the cooling system and the electronics, and;
the umbilical cables and the hand piece, which houses the
laser.

Intended Use of the Device: The MLT Erbium: YAG Laser System device is designed
specifically for superficial skin ablation resulting in skin
dermabrasion, and the treatment of wrinkles. In addition this
system is intended for coagulation, vaporization, ablation, or
cutting of soft tissue (skin) in dermatology, plastic surgery
(including aesthetic surgery), oral surgery, and ophthaimology.

KO 32599 Qf
Zor Z
INTRODUCTION .
The Medical Laser Technologies, LLC MLT Erbium: YAG Laser System is intended
for superficial skin ablation resulting in skin dermabrasion and the treatment of
wrinkles. In addition, the system is intended for coagulation, vaporization, ablation, or
cutting of soft tissue (skin) in dermatology, plastic surgery, (including aesthetic
surgery), ora) surgery and opthalmology. The laser system is designed for reliability,
for long life, and ease of use. As a result, no maintenance should be required other than
cleaning the instrument and an annual calibration check.
As with any laser system, appropriate care must be taken to ensure proper and safe use.
This entire manual should be thoroughly reviewed before operating the
instrument. Further, the physician should attend a certified laser-training course
before using the Medical Laser Technologies, LLC MLT Erbium: YAG Laser
System for medical treatment.
All users should become familiar with the requirements for safe use of medical
laser systems as described in the American National Standards Institute (ANSI)
publications, American National Standard for the Safe Use of Lasers in Health
Care Facilities (ANSI Z126.3-1983), AND, American National Standard for the
Safe Use of lasers (ANSI Z2136.1-1986). The information in this manual is provided
in accordance with these Standards.
Chapter 2 version 1.0 2
et
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Ce
"nen Food and Drug Administration
ocT 2 9 200 reas

Mr. Mark Rohrer
Managing Member
Medica! Laser Technologies, LLC .
516 Scott Street ,
Homewood, Alabama 35209
Re: K032599

Trade/Device Name: Medical Laser Technologies, LLC MLT Erbium: YAG Laser System

Regulation Number: 21 CFR 878.4810

Regulation Name: Laser surgical instrument for use in general and

plastic surgery and in dermatology :

Regulatory Class: II

Product Code: GEX

Dated: July 7, 2003

Received: August 27, 2003
Dear Mr. Rohrer:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to
devices that have been reclassified in accordance with the provisions of the Federal Food. Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration. listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class HI (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination dogs not mean
that FDA has made a determination that your device complies with other requirements of the \ct
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Mark Rohrer
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please ‘
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

, Petia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure : .

INDICATION FOR USE STATEMENT
510(K) Number: KO2 AD
Device Name: ‘ical Laser Technologies, LLC MLT Erbium: Y. Laser System
Indications for Use:

The MLT Erbium: YAG Laser System device is designed specifically for superficial skin
ablation resulting in skin dermabrasion, and the treatment of wrinkles. In addition this system
is intended for coagulation, vaporization, ablation, or cutting of soft tissue (skin) in
dermatology, plastic surgery (including aesthetic surgery), oral surgery, and ophthalmology.

(Please do not write below this line — continue on another page if needed)

(Division Sign-Off) .

Division of General, Restorative

and Neurological Devices

S
510(k) Number KO3aS4
Concurrence of CDRH, Office of Device Evaluation (OD

Prescription Use Y OR Over-the-Counter Use.
(per 21 CFR 801.109)

